Is Sensus Healthcare Inc (SRTS) overvalued? · P/E 42, rev $41.8M
Sensus Healthcare Inc (SRTS) is a medical devices company listed on US.
This page asks whether Sensus Healthcare Inc (SRTS) looks expensive on cached numbers — not a short thesis.
Latest reported SRTS revenue for 2024-12-31 was $41.8M. Net income was $6.6M. Revenue was up 71.3% from 2023-12-31 to 2024-12-31. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
SRTS currently screens at market cap $76.6M and trailing P/E 42.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SRTS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SRTS stock page for the full model, not this heading.
Not investment advice.